Skip to main content

Immunome Inc.

IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472012

In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Immunome Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IMNM: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3129−2
Shares1.91M2.38M+467.0K (+24.5%)
Value$64.7M$41.1M−$23.6M (−36.4%)

New holders (11)

Institutions that held Immunome Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to IMNM in Q2 2021
InstitutionSharesValue% of portfolio
Ridgewood Investments LLC58,013$1.00M0.64%
Millennium Management LLC36,670$634.0K0.00%
Two Sigma Investments, LP29,516$511.0K0.00%
Sterling Investment Advisors, Ltd.21,627$374.0K0.11%
Renaissance Technologies LLC20,400$353.0K0.00%
Neuberger Berman Group LLC19,444$336.0K0.00%
Wetherby Asset Management Inc17,881$309.0K0.02%
ExodusPoint Capital Management, LP12,800$221.0K0.00%
Wealth Architects, LLC11,201$194.0K0.04%
Ergoteles LLC10,006$173.0K0.00%
Simplex Trading, LLC100$1.00K0.00%

Sold out (13)

Institutions that held Immunome Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of IMNM in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
State Street Corp32,550$1.10M
Northern Trust Corp27,114$918.0K
Baldwin Investment Management, LLC25,394$860.0K
California State Teachers Retirement System3,161$107.0K
O'Shaughnessy Asset Management, LLC1,599$54.0K
Bank of America Corp1,485$51.0K
STRS Ohio1,400$47.0K
Deutsche Bank AG1,340$45.0K
American International Group, Inc.1,218$41.0K
Legal & General Group Plc207$7.00K
Ameritas Investment Partners, Inc.175$6.00K
Citigroup Inc140$5.00K
Bank of Montreal59$2.00K